US General Surgical Devices Market Size Likely to Grow at a CAGR of 7.8% By 2035

The general surgical devices market size in the US is estimated to be USD 18.42 billion in 2025 and it is projected that such a market size will swell to USD 19.86 billion in 2026 and to about USD 35.28 billion between 2026 and 2035 with an annual CAGR of 7.8%.

US General Surgical Devices Market Revenue and Trends

This industry has a wide variety of instruments and equipment such as scalpels, forceps, scissors, retractors, electrosurgical generators and instruments, surgical staplers and reloads, suture and needle holders, trocars and access devices, suction and irrigation systems, laparoscopic hand instruments, energy based vessel sealers and dissectors, and powered surgical devices, which are utilized in the open, laparoscopic, and robotic-assisted procedures in general surgery, colorectal surgery, and gynecologic surgery.

The US general surgical devices are increasing at a very high rate, owing to the high volume of surgical procedures annually, the ongoing migration of surgical procedures to minimally invasive and robotic systems, obesity, colorectal cancer, and gallbladder malady are increasingly subject to surgical intervention, the aging population promotes elective and emergency cases, and powered stapling and advanced energy devices, single-use instruments, and smart surgical tools are in hospital and ambulatory surgery settings.

What are the Factors That Have a Significant Contribution to the Growth of the US general surgical devices market?

Demand for specialized general surgical equipment has increased due to the popularity of minimally invasive and robotic assisted general surgery especially in the bariatric, colorectal, hernia repair, cholecystectomy, and appendectomy procedures due to the rapid recovery, reduced hospital stay, reduced complication rates and good reimbursement of outpatient surgeries by the CMS. Due to the increasing case acuity and the high OR throughput of hospitals, where ASCs are increasingly conducting higher-acuity cases, more facilities are in need of dependable, ergonomically sound, and technologically advanced apparatus to help in facilitating efficient case turnover and surgeon preference.

Practices such as the implementation of intelligent powered staplers that have tissue compression sensing and real-time feedback, enhanced bipolar and ultrasonic energy platforms with better seal and cutting abilities, single-use laparoscopic tooling that has better articulation, robotic compatible trocars and accessories; built-in OR connectivity; and data-driven performance monitoring have been introduced through technological advancements and have improved precision, safety and workflow efficiency. The other factors consist of the good reimbursement climate on outpatient surgery, the rising use of private equity in ASC chains, the rising preference of surgeons to use high quality single-use and powered tools, strong clinical support on MIS results, and the continuous cycle of replacement of capital equipment in the hospitals.

Segment Insight

By Product Type

Viewed by products, surgical staplers and reloads constituted by far the largest fraction of the US general surgical devices market as of 2025, which is due to their high use in colorectal, bariatric, thoracic, and general abdominal surgical procedures to reliably anastomose, ligate vessels, and transect tissues, and to further innovate powered stapling platforms, intelligent reloads, and reinforced staple lines, of which large numbers of general, colorectal, and bariatric surgeons report as having superior tools for reducing leaks, bleeding, and operative time while supporting complex MIS and robotic cases.

By Distribution Channel

The greatest market share is found in hospitals and ambulatory surgical centers which represent the main centers of procuring the high quality surgical staplers, energy equipment, laparoscopic equipment, and single use equipment via group purchasing organizations (GPOs), direct vendor contracts, and value analysis committees. As these channels offer professional skills to align the preferences of surgeons, clinical trials and assessments, OR integration support, and adherence to infection control and cost-containment measures, they have become the channels of choice in sourcing generic surgical equipment.

Report Scope

Recent Developments

• In June 2025: Johnson & Johnson MedTech launched the next-generation Echelon Circular™ Powered Stapler with enhanced Gripping Technology and real-time tissue compression feedback, achieving widespread adoption in colorectal and thoracic programs across major US health systems for improved anastomotic integrity and reduced leak rates.

List of the prominent players in the US General Surgical Devices Market:

• Medtronic plc

• Johnson & Johnson (Ethicon)

• Stryker Corporation

• B. Braun Melsungen AG

• Becton Dickinson and Company

• Smith & Nephew plc

• Zimmer Biomet Holdings Inc.

• 3M Company

• Integra LifeSciences Holdings Corporation

• ConMed Corporation

• Teleflex Incorporated

• Applied Medical Resources Corporation

• Others

The US General Surgical Devices Market is segmented as follows:

By Product Type

• Surgical Sutures & Staplers

  • Absorbable Sutures

  • Non-Absorbable Sutures

  • Surgical Staplers

• Handheld Surgical Instruments

  • Forceps & Clamps

  • Scalpels & Blades

  • Scissors

  • Retractors

• Electrosurgical Devices

  • Monopolar Devices

  • Bipolar Devices

  • Ultrasonic Devices

• Surgical Kits

• Disposable Surgical Supplies

• Others

By Application

• Cardiovascular Surgery

• Orthopedic Surgery

• Neurosurgery

• Plastic & Reconstructive Surgery

• General Surgery

  • Abdominal Surgery

  • Bariatric Surgery

  • Colorectal Surgery

• Others

By End User

• Hospitals

• Ambulatory Surgical Centers

• Specialty Clinics

• Others

By Surgery Type

• Open Surgery

• Minimally Invasive Surgery

• Robotic-Assisted Surgery